These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31529482)

  • 41. Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.
    Miyamoto M; Takano M; Aoyama T; Soyama H; Yoshikawa T; Tsuda H; Furuya K
    J Gynecol Oncol; 2018 Mar; 29(2):e20. PubMed ID: 29400013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Endometrial hyperplasia predicts a better prognosis in endometrial carcinoma].
    Mihailovici MS; Teleman S
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):367-70. PubMed ID: 14755942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparanase expression increases throughout the endometrial hyperplasia-cancer sequence.
    Canaani J; Ilan N; Back S; Gutman G; Vlodavsky I; Grisaru D
    Int J Gynaecol Obstet; 2008 May; 101(2):166-71. PubMed ID: 18221741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of uteroglobin in normal and carcinogenic endometrium and influence of hormone replacement therapy.
    Tanaka R; Saito T; Shijubo N; Takehara M; Yamada G; Kawabata I; Itoh Y; Kudo R
    Int J Cancer; 2004 Mar; 109(1):43-8. PubMed ID: 14735466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
    Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies.
    Watanabe K; Sasano H; Harada N; Ozaki M; Niikura H; Sato S; Yajima A
    Am J Pathol; 1995 Feb; 146(2):491-500. PubMed ID: 7856758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
    Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
    Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium.
    Flannery CA; Fleming AG; Choe GH; Naqvi H; Zhang M; Sharma A; Taylor HS
    Endocrinology; 2016 Oct; 157(10):3699-3708. PubMed ID: 27267714
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
    Lax SF
    Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.
    Ambros RA; Sherman ME; Zahn CM; Bitterman P; Kurman RJ
    Hum Pathol; 1995 Nov; 26(11):1260-7. PubMed ID: 7590702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of bcl-2 in endometrioid corpus cancer: an experimental study.
    Mariani A; Sebo TJ; Cliby WA; Keeney GL; Riehle DL; Lesnick TG; Podratz KC
    Anticancer Res; 2006; 26(2A):823-7. PubMed ID: 16619475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Levels of estrogen and progesterone receptors in premalignant and malignant states in the endometrium].
    Jokanović L; Cvrtila D; Klarić P; Kanajet D
    Jugosl Ginekol Perinatol; 1991; 31(3-4):49-51. PubMed ID: 1749274
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression and clinical significance of ghrelin in endometrial hyperplasia and carcinoma of Egyptian patients.
    Younes SF; Aiad H; Kandil M; El Kalashy FS
    Ultrastruct Pathol; 2015 May; 39(3):207-13. PubMed ID: 25569277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel molecular profiles of endometrial cancer-new light through old windows.
    Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.
    Gan Q; Crumley S; Broaddus RR
    Int J Gynecol Pathol; 2019 Jan; 38(1):44-51. PubMed ID: 29210800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Membrane expression of the death ligand trail receptors DR4 and DR5 in the normal endometrium, endometrial atypical hyperplasia and endometrioid endometrial cancer.
    Gottwald L; Szwalski J; Piekarski J; Pasz-Walczak G; Kubiak R; Spych M; Suzin J; Tyliński W; Sęk P; Jeziorski A
    J Obstet Gynaecol; 2013 Jul; 33(5):512-8. PubMed ID: 23815209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
    Corrado G; Baiocco E; Carosi M; Vizza E
    Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.